Maggie Yuen Penumbra Inc (PEN) insider trading activity

Maggie Yuen is Chief Financial Officer of Penumbra Inc. Currently has a direct ownership of 15,957 shares of PEN, which is worth approximately $4.27 Million. The most recent transaction as insider was on Mar 15, 2025, when has been sold 186 shares (Common Stock) at a price of $272.62 per share, resulting in proceeds of $50,707. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16K

8.52% 3M change

21.54% 12M change

Total Value Held $4.27 Million

Maggie Yuen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 15 2025	SELL Payment of exercise price or tax liability	$50,707 $272.62 p/Share	186 Reduced 1.15%	15,957 Common Stock
Mar 05 2025	BUY Exercise of conversion of derivative security	$142,470 $158.3 p/Share	900 Added 5.28%	16,143 Common Stock
Mar 03 2025	SELL Open market or private sale	$571,600 $285.8 p/Share	2,000 Reduced 11.6%	15,243 Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$21,962 $271.14 p/Share	81 Reduced 0.47%	17,243 Common Stock
Feb 18 2025	BUY Grant, award, or other acquisition	-	1,840 Added 9.6%	17,324 Common Stock
Feb 14 2025	BUY Grant, award, or other acquisition	-	780 Added 4.8%	15,484 Common Stock
Dec 15 2024	SELL Payment of exercise price or tax liability	$147,084 $245.55 p/Share	599 Reduced 3.91%	14,704 Common Stock
Nov 15 2024	SELL Payment of exercise price or tax liability	$119,871 $237.84 p/Share	504 Reduced 3.19%	15,296 Common Stock
Nov 15 2024	BUY Grant, award, or other acquisition	-	2,570 Added 13.99%	15,800 Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$42,874 $222.15 p/Share	193 Reduced 1.45%	13,129 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	2,070 Added 13.45%	13,322 Common Stock
Dec 16 2023	SELL Payment of exercise price or tax liability	$147,778 $245.48 p/Share	602 Reduced 5.08%	11,252 Common Stock
Dec 15 2023	SELL Payment of exercise price or tax liability	$94,509 $245.48 p/Share	385 Reduced 3.15%	11,854 Common Stock
Nov 15 2023	SELL Payment of exercise price or tax liability	$106,192 $227.88 p/Share	466 Reduced 3.67%	12,221 Common Stock
Dec 16 2022	SELL Payment of exercise price or tax liability	$134,059 $223.06 p/Share	601 Reduced 4.56%	12,588 Common Stock
Dec 15 2022	BUY Grant, award, or other acquisition	-	4,450 Added 25.23%	13,189 Common Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	$63,696 $195.99 p/Share	325 Reduced 3.59%	8,738 Common Stock
Dec 16 2021	SELL Payment of exercise price or tax liability	$226,344 $247.1 p/Share	916 Reduced 9.29%	8,939 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	3,750 Added 27.71%	9,785 Common Stock
Dec 16 2020	SELL Payment of exercise price or tax liability	$160,107 $174.98 p/Share	915 Reduced 13.17%	6,035 Common Stock
Dec 16 2019	BUY Grant, award, or other acquisition	-	6,950 Added 50.0%	6,950 Common Stock

Also insider at

ATRC

AtriCure, Inc. Healthcare

Director

Maggie Yuen

Chief Financial Officer

Alameda, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PEN shares.

Notify only if

Value

Insider Trading

Get notified when an Penumbra Inc insider buys or sells PEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Penumbra Inc

Track Activities on PEN

Account